WETLAB



Cortisol aptasensor formation and sensitivity

Iteration 1 Iteration 2 Iteration 3

Formation using truncated aptamer and cDNA


Design



The truncated aptamer sequence was referred to us by Dr. Tarun Kumar Sharma from Gujarat Biotechnology University. This aptamer is a 14-mer, which is claimed to conform and bind to one of the prominent binding sites of the cortisol biomolecule. The cDNA (complementary ssDNA) was designed to complement the half length of the aptamer, making the cDNA 7bp long. Given below are the possible conformations of the 14-mer aptamer sequence obtained using DNA-fold software:



Test



To check if the truncated aptamer and cDNA were binding, a fluorescence-based test was performed using the flurolog equipment (the working of which is mentioned on the experiment page). The fluorescence-based tests were used to measure the optimum molar ratio between the aptamer and the cDNA and the incubation time required to form the aptasensor. To check the sensitivity of the truncated aptasensor and to determine the efficiency and working of the aptasensor, we performed plate reader experiments.



Build



The aptamer sequence was modified with a 5' fluorophore attachment, and the cDNA was modified with a quencher towards the 3' end. The fluorophore and quencher pair were decided based on their FRET efficiency. Our ideal choice for the fluorophore was fluorescein-based FAM with an excitation peak at 498 nm and an emission peak at 517 nm, and the quencher of choice was BHQ1, which has an absorption range of 480 to 580 nm with maximum absorption at 534 nm. The possible structure of the aptamer cDNA complex is given below:



Learn



We only observed a 10 per cent quenching from the above experimental data in 90 minutes. As shown above, the optimum molar ratio of 1:2 (trunc aptamer: cDNA) was used for the sensitivity experiment. The chosen aptasensor is not very sensitive within the range of 100 to 300 ng/ml cortisol, the physiological range in the human blood serum. Therefore, there are better quantifiers for cortisol biomolecules than the truncated aptasensor.


Serotonin aptasensor formation and sensitivity

44-mer serotonin aptamer and 20-mer cDNA


Learn



The results above show that the hybridization of the cDNA and aptamer causes an increase in fluorescence. In contrast, the interaction between the fluorophore quencher pair should cause a decrease in fluorescence. This could be because the partial binding of the cDNA occurred elsewhere within the aptamer, causing a change in the conformation of the aptamer, thereby exposing the fluorophore molecule. This theory would explain the increase in fluorescence over time observed after the hybridization of the cDNA with the aptamer.



Design



The 44-mer aptamer was derived from the literature obtained from [r]; the possible conformations of the serotonin aptamer are given below. The aptamer had a kd value of -30 nm and a delta g value of -10.62 kcal/mol. This version of the cDNA was designed based on the kD value of the aptamer; the cDNA pair compared to the kD value of the serotonin binding with the 44-mer aptamer. As shown below, multiple complementary sequences were designed to find a sequence with a higher kD value than -30.1 that would not affect the binding and formation of the designed FRET system. The chosen cDNA had a kD value of -9.9 kcal/mol, and the possible conformation didn’t affect the binding position of the cDNA, hence the interaction of the fluorophore quencher pair.



Build



The aptamer sequence was modified with a 5' fluorophore attachment, and the cDNA was modified with a quencher towards the 3' end. The fluorophore and quencher pair were decided on their FRET efficiency; our ideal choice of the fluorophore was FAM, which is a fluorescein-based fluorophore with an excitation peak at 498 nm and an emission peak at 517 nm, and the quencher of choice was BHQ1 which has an absorption range of BHQ1 is from 480 to 580 nm with maximum absorption at 534 nm. These sequences were then ordered from IDT for further testing. Attached below is the possible hybridised duplex structure acquired using the duplex fold software Attached below are the possible hybridised duplex structures acquired using the duplex fold software: Link
https://rna.urmc.rochester.edu/RNAstructureWeb/Servers/DuplexFold/DuplexFold.html



Test



To check if the 44-mer serotonin aptamer and the designed cDNA were binding, a fluorescence-based test was performed using the Teacan plate reader equipment (working is mentioned in the experiment page” link”) to confirm binding between the aptamer and cDNA. We also conducted an isothermal titration calorimetric experiment to obtain the kD and delta g value; the fluorescence-based tests were used to measure the ideal molar ratio between the aptamer and the cDNA and the incubation time required for the formation of the aptasensor. To check the sensitivity of the obtained aptasensor, we performed plate reader experiments to determine the efficacy and detection limit of the aptasensor.



DRYLAB DBTL CYCLES




Learn



Due to the various challenges involved, and our lack of knowledge about how to modify the aptamer sequence to achieve effective turn-on, clickmer-based quantifiers are not a viable option at this time.



Design



  • Aptamers are short, single-stranded DNA or RNA molecules that can bind to specific target molecules with high affinity and specificity. To create a fluorescent aptasensor, aptamers can be modified with an alkyne group at one end. This alkyne group can then be attached to an azide fluorescent dye using a copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction.
  • When the aptamer binds to its target biomolecule, it undergoes a conformational change that exposes the azide group on the fluorescent dye. The CuAAC reaction can then occur, attaching the fluorescent dye to the aptamer. This results in a fluorescent signal that can be detected using a fluorometer or microplate reader.
  • This method of creating a fluorescent aptasensor is called a "turn-on" mechanism because the fluorescence signal is only present when the aptamer is bound to its target biomolecule. This is in contrast to a "turn-off" mechanism, in which the fluorescence signal is present when the aptamer is not bound to its target biomolecule.
  • Turn-on mechanisms are generally more desirable for aptasensors because they are more sensitive and less prone to false positives.


  • Build



    We used Integrated DNA Technologies (IDT) modifications to add an azide group to our selected aptamers. We planned to purchase Cy3-alkyne dye and perform a copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction to label the aptamers with the dye. https://rna.urmc.rochester.edu/RNAstructureWeb/Servers/DuplexFold/DuplexFold.html



    Test



    We pitched this idea to multiple faculty members within our institute and Dr. Reji Varghese made us aware of the possible difficulties such as the efficiency of a click binding and also the difficulty in modifying a certain nucleotide within an aptamer sequence that is known to be attached to the binding site of the biomolecule.



    HARDWARE DBTL CYCLES



    Learn



    The led was able to detect higher intensities well but could not respond to lower levels of light. We would need a more sensitive unconventional but cheap sensor.



    Design



    A container containing a source to mimic fluorescence (green which is expected from biological samples), a sensor to detect it and a self-contained microcontroller module for data collection and display



    Build



    Box out of Cardboard, green led used as a source, used a photodiode for its high sensitivity to green light and fast response times and Arduino Uno as the microcontroller



    Test



    Setup the container in a dark room with Arduino powered and outputting data to a laptop. Varied the voltage across the led in several small steps to achieve lowest possible levels of light via direct control from Arduino




    References



    1. Tolentino, J. C., & Schmidt, S. L. (2018). DSM-5 Criteria and Depression Severity: Implications for Clinical Practice. Frontiers in psychiatry, 9, 450. doi.org/10.3389/fpsyt.2018.00450 https://doi.org/10.3389/fpsyt.2018.00450 (1 December 2011)- World Health Organisation.
    2. https://www.who.int/news-room/fact-sheets/detail/depression